from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1286/cysN

LFCtreatmentdescriptionclass of inhibitor

-0.658

Amikacinug/mL Amikacintranslation

-0.011

Cap5-10ug/mL Capreomycintranslation

1.736

Rox10-50 ug/mL Roxithromycintranslation

0.940

SM2-5 ug/mL Streptomycintranslation

-0.784

Tet5-10 ug/mL Tetracyclinetranslation

-1.023

Rif0.2-5ug/mL Rifampicintranscription

0.239

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.533

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.343

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.259

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.250

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.291

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

2.688

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.026

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.098

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.742

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.580

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.126

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

1.356

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.682

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.823

KCN5-20 ug/mL Potassium cyaniderespiration

0.862

NaN30.2-2 mM Sodium aziderespiration

-0.405

Nigericin50 uM Nigericinrespiration

0.027

TRC10-150 ug/mL Triclosanrespiration

-0.041

TRZ10-25 ug/mL Thioridazinerespiration

-0.105

Valinomycin0.5-10 uM Valinomycinrespiration

-1.319

ZnSO42 mM ZnSO4respiration

-0.735

menadione6-10 ug/mL Menadionerespiration

0.180

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.463

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.375

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.970

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

1.484

NRP_1Non-replicating persistence stage 1dosRassociated

-0.152

Amp0.2mg/mL AmpicillincellWall

-0.740

Cephalexin20-100 ug/mL CephalexincellWall

0.096

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.728

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.384

EMB10-20 ug/mL EthambutolcellWall

-1.043

Eta12-40 ug/mL EthionamidecellWall

-1.306

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.282

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.530

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.140

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.655

BZA0.12 mg/mL BenzamidearomaticAmides

0.583

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

1.131

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.403

H2O24 mM hydrogen peroxideDNAdamaging

-0.430

Levo10 ug/mL LevofloxacinDNAdamaging

-0.314

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.586

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.929

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.780

UVUV-irradiationDNAdamaging

-0.398

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.580

Antimycin12.5-50 ug/mL Antimycin A?

-0.366

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.333

PA_110-50 ug/mL Antitubercular compound PA-1?

0.042

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.913

PA8240.2-2 ug/mL PA-824?

0.531

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.645

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.926

Verapamil50 uM Verapamil?

-0.456

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.333

methoxatin10-20 ug/mL Methoxatin?